HLS Therapeutics
A corporate director with over 30 years of health care experience in corporate and non-profit organizations, including executive positions at Bayer Healthcare (Canada and Global) and Sanofi Canada.
Ms. Beauchamp currently serves on the boards of directors of Aurora Cannabis Inc. (TSX: ACB) (“Aurora”), as Chair of its Nominating and Corporate Governance Committee and a member of its Human Resources and Compensation Committee, Extendicare Inc. (TSX:EXE), as a member of the Investment Committee and the Quality and Risk Committee, and Dialogue Health Technologies Inc. (TSX:CARE), a leading telehealth service. Formerly, Ms. Beauchamp served on the board of directors of MedReleaf Corp., prior to its acquisition by Aurora. Ms. Beauchamp also serves as a member of the National Research Council of Canada, is on the board of the Ontario Caregiver Organization, and is a Regional Ambassador with Women Get on Board. Ms. Beauchamp has completed the University of Toronto’s Rotman School of Management Directors Education Program (ICD.D), and holds a Bachelor of Business Administration in Marketing from Bishop’s University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices